Results of large-scale trials conducted among infants in South Africa released Monday showed the most promising vaccine to replace the world's 91-year-old tuberculosis jab does not protect against the disease. Doctors have had high hopes for the formula, known as MVA85A, as the existing Bacille-Calmette-Guerin (BCG) vaccine does not protect against pulmonary TB, the most common form of the disease among adults and adolescents. MVA85A was found to be ...Wednesday, 6 February 2013
Most Promising Tuberculosis Vaccine Proved Unsuccessful in Large Scale Trials
Results of large-scale trials conducted among infants in South Africa released Monday showed the most promising vaccine to replace the world's 91-year-old tuberculosis jab does not protect against the disease. Doctors have had high hopes for the formula, known as MVA85A, as the existing Bacille-Calmette-Guerin (BCG) vaccine does not protect against pulmonary TB, the most common form of the disease among adults and adolescents. MVA85A was found to be ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment